chevron_leftBack
As of 5 June 2026, Vitrafy Life Sciences Ltd. has a market cap of $94.78M USD, ranking #25950 globally and #601 in Australia.
It ranks #2330 in the Healthcare sector, and #483 in the Medical Devices industry.
Key Stats
Market Cap
$94.78MUSD
132.81M AUD
Enterprise Value
$78.75MUSD
110.36M AUD
Revenue (TTM)
$1.67MUSD
2.34M AUD
EBITDA (TTM)
-$11.55MUSD
-16.19M AUD
Net Income (TTM)
-$10.1MUSD
-14.15M AUD
PS Ratio
56.7
PB Ratio
6.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Brenton Michael Owens
open_in_new
Employees
22
Founded
2017
Website
vitrafy.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 5.3% | 12% | 25% | 13% | 45% | 45% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
VFY
Vitrafy Life Sciences Ltd
ISIN: AU0000361297
Shares Out.:
Shares Outstanding:
63.85M1
Shares Float:
46.094M2
|
2.19 AUD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company’s cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
ASX: COH
|
$4.2B
4K%
5.89B AUD
|
17.1
|
|
NZE: EBO
|
$2.55B
3K%
4.34B NZD
|
16.0
|
|
ASX: CU6
|
$786.34M
730%
1.1B AUD
|
-
|
|
ASX: NAN
|
$743.12M
684%
1.04B AUD
|
52.3
|
|
ASX: TTX
|
$171.0M
80%
239.61M AUD
|
-
|
|
ASX: OCC
|
$170.38M
80%
238.75M AUD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
183K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
169K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
168K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
133K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
127K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
107K%
|
22.2
|
chevron_leftBack